Cargando…

Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial

BACKGROUND: The importance of 2-yr postradiotherapy prostate biopsy status remains uncertain. OBJECTIVE: To assess the value of 2 year post treatment biopsies in a randomised trial of radiotherapy dose escalation. DESIGN, SETTING, AND PARTICIPANTS: Between 1998 and 2001, 843 men with localised prost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kass-Iliyya, Antoine, Jovic, Gordana, Murphy, Claire, Fisher, Cyril, Syndikus, Isabel, Jose, Chakiath, Scrase, Christopher D., Graham, John D., Nicol, David, Sydes, Matthew R., Dearnaley, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954168/ https://www.ncbi.nlm.nih.gov/pubmed/29307509 http://dx.doi.org/10.1016/j.eururo.2017.12.017

Ejemplares similares

Accuracy and Reproducibility of Conformal Radiotherapy using Data from a Randomised Controlled Trial of Conformal Radiotherapy in Prostate Cancer (MRC RT01, ISRCTN47772397)
por: Stanley, S., et al.
Publicado: (2008)

Late Gastrointestinal Toxicity After Dose-Escalated Conformal Radiotherapy for Early Prostate Cancer: Results From the UK Medical Research Council RT01 Trial (ISRCTN47772397)
por: Syndikus, Isabel, et al.
Publicado: (2010)

Imaging Features of Postradiotherapy Changes in Head and Neck Cancers
por: Gehani, Anisha, et al.
Publicado: (2021)

Cancer and Postradiotherapy Cardiotoxicity: How to Face Damage in Women’s Hearts?
por: Peix, Amalia, et al.
Publicado: (2023)

Symptom clusters for revising scale membership in the analysis of prostate cancer patient reported outcome measures: a secondary data analysis of the Medical Research Council RT01 trial (ISCRTN47772397)
por: Lemanska, Agnieszka, et al.
Publicado: (2017)

Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials
por: Dearnaley, David P, et al.
Publicado: (2009)

Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial
por: Sydes, Matthew R, et al.
Publicado: (2009)

Postradiotherapy small cell neuroendocrine carcinoma of base of tongue: An unusual clinical and site presentation
por: Jha, V, et al.
Publicado: (2017)

Bilateral thalamic and mesencephalic infarctions with hypopituitarism as long-term complications postradiotherapy: A case report
por: Hui, Liang, et al.
Publicado: (2018)

MRC2020: improvements to Ximdisp and the MRC image-processing programs
por: Short, J. M., et al.
Publicado: (2023)

MRC2014: Extensions to the MRC format header for electron cryo-microscopy and tomography
por: Cheng, Anchi, et al.
Publicado: (2015)

Patient-specific forecasting of postradiotherapy prostate-specific antigen kinetics enables early prediction of biochemical relapse
por: Lorenzo, Guillermo, et al.
Publicado: (2022)

Small Fibre Neuropathy in Parkinson’s Disease: Comparison of Skin Biopsies from the More Affected and Less Affected Sides
por: Jeziorska, Maria, et al.
Publicado: (2019)

Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity
por: Naismith, O.F., et al.
Publicado: (2019)

Subdural empyema complicated with intracranial hemorrhage in a postradiotherapy nasopharyngeal carcinoma patient: A case report and review of literature
por: Chen, Jun-Chen, et al.
Publicado: (2018)

Antibiotic therapy for the prevention of osteoradionecrosis following tooth extraction in head-and-neck cancer patients postradiotherapy: An 11-year retrospective study
por: Palma, Luiz Felipe, et al.
Publicado: (2021)

Fluorodeoxyglucose-positron emission tomography in carcinoma nasopharynx: Can we predict outcomes and tailor therapy based on postradiotherapy fluorodeoxyglucose-positron emission tomography?
por: Laskar, Sarbani Ghosh, et al.
Publicado: (2016)

Historical Perspectives of the Role of the MRC
por: Williams, P. O.
Publicado: (1990)

Glycine receptor antibodies and coeliac disease-related neurological dysfunction
por: Kass-Iliyya, Lewis, et al.
Publicado: (2021)

Incidence and long‐term outcome of postradiotherapy moyamoya syndrome in pediatric patients with primary brain tumors: a single institute experience in Taiwan
por: Wu, Yuan‐Hung, et al.
Publicado: (2016)

Patient survival after D (1) and D (2) resections for gastric cancer: long-term results of the MRC randomized surgical trial
por: Cuschieri, A, et al.
Publicado: (1999)

Effects of continuity of care on the postradiotherapy survival of working-age patients with oral cavity cancer: A nationwide population-based cohort study in Taiwan
por: Kuo, Tsu Jen, et al.
Publicado: (2019)

Marginal structural models with dose-delay joint-exposure for assessing variations to chemotherapy intensity
por: Lancia, Carlo, et al.
Publicado: (2018)

The value of evidence synthesis in randomised controlled trial (RCT) design, conduct and analysis: MRC clinical trials unit (CTU) at UCL experience
por: Tierney, Jayne F, et al.
Publicado: (2015)

Cohort differences in disease and disability in the young-old: findings from the MRC Cognitive Function and Ageing Study (MRC-CFAS)
por: Jagger, Carol, et al.
Publicado: (2007)

Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience
por: Adams, R A, et al.
Publicado: (2009)

Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial
por: Hale, Matthew D., et al.
Publicado: (2016)

The treatment of multiple myeloma--an important MRC trial.
por: Johnson, P. W., et al.
Publicado: (1994)

Microscale oxygraphy reveals OXPHOS impairment in MRC mutant cells
por: Invernizzi, F., et al.
Publicado: (2012)

Flexible trial design in practice – dropping and adding arms in STAMPEDE: a multi-arm multi-stage randomised controlled trial
por: Sydes, Matthew R, et al.
Publicado: (2011)

Method to measure the mismatch between target and achieved received dose intensity of chemotherapy in cancer trials: a retrospective analysis of the MRC BO06 trial in osteosarcoma
por: Lancia, Carlo, et al.
Publicado: (2019)

Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP Trial
por: Tree, Alison, et al.
Publicado: (2022)

Colocalization of Mec1 and Mrc1 is sufficient for Rad53 phosphorylation in vivo
por: Berens, Theresa J., et al.
Publicado: (2012)

ExpMRC: explainability evaluation for machine reading comprehension
por: Cui, Yiming, et al.
Publicado: (2022)

Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial
por: Sydes, Matthew R, et al.
Publicado: (2012)

Mrc1 protects uncapped budding yeast telomeres from exonuclease EXO1
por: Tsolou, Avgi, et al.
Publicado: (2007)

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)
por: Dearnaley, David, et al.
Publicado: (2019)

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial
por: Madi, A, et al.
Publicado: (2012)

Comparative Transcriptome Profiling of an SV40-Transformed Human Fibroblast (MRC5CVI) and Its Untransformed Counterpart (MRC-5) in Response to UVB Irradiation
por: Chang, Cheng-Wei, et al.
Publicado: (2013)

A simulated sequential analysis based on data from two MRC trials.
por: Donaldson, A. N., et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_kv01jhub8rkf8q7kr14qs0b2am